Plasma pharmacokinetics of a human insulin receptor antibody-iduronidase fusion protein in patients with mucopolysaccharidosis type I

MLA

Ruben J. Boado, et al. “Plasma Pharmacokinetics of a Human Insulin Receptor Antibody-Iduronidase Fusion Protein in Patients with Mucopolysaccharidosis Type I.” Molecular Genetics and Metabolism, vol. 123, Feb. 2018, p. S113. EBSCOhost, https://doi.org/10.1016/j.ymgme.2017.12.303.

APA

Ruben J. Boado, Mathias Schmidt, William M. Pardridge, & Roberto Giugliani. (2018). Plasma pharmacokinetics of a human insulin receptor antibody-iduronidase fusion protein in patients with mucopolysaccharidosis type I. Molecular Genetics and Metabolism, 123, S113. https://doi.org/10.1016/j.ymgme.2017.12.303

Chicago

Ruben J. Boado, Mathias Schmidt, William M. Pardridge, and Roberto Giugliani. 2018. “Plasma Pharmacokinetics of a Human Insulin Receptor Antibody-Iduronidase Fusion Protein in Patients with Mucopolysaccharidosis Type I.” Molecular Genetics and Metabolism 123 (February): S113. doi:10.1016/j.ymgme.2017.12.303.